Track topics on Twitter Track topics that are important to you
Lazard Ltd (NYSE: LAZ) announced today that Lord David Prior, the former Under Secretary of State to the Department for Business, Energy and Industrial Strategy (BEIS) and Ministe...
Verastem Inc. (aka Verastem Oncology; developing cancer therapeutics) netted $146mm through a registered direct offering of $150mm principal amount of its 5% senior notes due November 1, 2048. The not...
– Andrew Dickinson Promoted to Executive Vice President, Corporate Development and Strategy;Martin Silverstein, Executive Vice President, Strategy, to Leave Gilead at End of Aug...
Lazard, one of the world's preeminent financial advisory and asset management firms, operates from 43 cities across 27 countries in North America, Europe, Asia, Australia, Central...
Lazard provides a full range of financial advisory services to a diverse group of clients world-wide. Lazard Technology Partners is a venture capital firm dedicated to providing investors with superio...
Lazard Ltd began trading on the New York Stock Exchange on May 5, 2005 under the ticker symbol "LAZ". Lazard, the world's preeminent advisory investment bank, has offices in 16 countries around the gl...
We have published hundreds of Lazard Ltd news stories on BioPortfolio along with dozens of Lazard Ltd Clinical Trials and PubMed Articles about Lazard Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lazard Ltd Companies in our database. You can also find out about relevant Lazard Ltd Drugs and Medications on this site too.
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.